Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of HSK3486 and Rifampin in Healthy Subjects
NCT03758469Phase 1Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Dec 2018
- Primary completion
- Jan 2019
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ciprofol in general anesthesia and Procedural sedation (PS) (2 arms), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd. Primary endpoints: Peak concentration at 24 hours, Area under the concentration-time curve from time zero to the last measurable concentration at 24 hours and 1 more. Started Dec 2018; status: completed.
02
Drugs
ciprofol
03
Conditions
general anesthesiaProcedural sedation (PS)
Beyond the preview
Go deeper on NCT03758469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03758469.